vs
Side-by-side financial comparison of Brookfield Renewable Corp (BEPC) and Dexcom (DXCM). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $952.0M, roughly 1.3× Brookfield Renewable Corp). Dexcom runs the higher net margin — 21.2% vs -152.0%, a 173.2% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs -3.7%).
Brookfield Renewable Partners L.P. is a publicly traded limited partnership that owns and operates renewable power assets, with corporate headquarters in Toronto, Ontario, Canada. It is 60% owned by Brookfield Asset Management.
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
BEPC vs DXCM — Head-to-Head
Income Statement — Q2 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $952.0M | $1.3B |
| Net Profit | $-1.4B | $267.3M |
| Gross Margin | — | 62.9% |
| Operating Margin | — | 25.6% |
| Net Margin | -152.0% | 21.2% |
| Revenue YoY | -3.7% | 21.6% |
| Net Profit YoY | -326.8% | 153.6% |
| EPS (diluted) | — | $0.67 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.3B | ||
| Q4 25 | — | $1.3B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | $952.0M | $1.2B | ||
| Q1 25 | — | $1.0B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $994.2M | ||
| Q2 24 | $989.0M | $1.0B |
| Q1 26 | — | $267.3M | ||
| Q4 25 | — | $267.3M | ||
| Q3 25 | — | $283.8M | ||
| Q2 25 | $-1.4B | $179.8M | ||
| Q1 25 | — | $105.4M | ||
| Q4 24 | — | $151.7M | ||
| Q3 24 | — | $134.6M | ||
| Q2 24 | $-339.0M | $143.5M |
| Q1 26 | — | 62.9% | ||
| Q4 25 | — | 62.9% | ||
| Q3 25 | — | 60.5% | ||
| Q2 25 | — | 59.5% | ||
| Q1 25 | — | 56.9% | ||
| Q4 24 | — | 58.9% | ||
| Q3 24 | — | 59.7% | ||
| Q2 24 | — | 62.4% |
| Q1 26 | — | 25.6% | ||
| Q4 25 | — | 25.6% | ||
| Q3 25 | — | 20.1% | ||
| Q2 25 | — | 18.4% | ||
| Q1 25 | — | 12.9% | ||
| Q4 24 | — | 17.0% | ||
| Q3 24 | — | 15.3% | ||
| Q2 24 | — | 15.7% |
| Q1 26 | — | 21.2% | ||
| Q4 25 | — | 21.2% | ||
| Q3 25 | — | 23.5% | ||
| Q2 25 | -152.0% | 15.5% | ||
| Q1 25 | — | 10.2% | ||
| Q4 24 | — | 13.6% | ||
| Q3 24 | — | 13.5% | ||
| Q2 24 | -34.3% | 14.3% |
| Q1 26 | — | $0.67 | ||
| Q4 25 | — | $0.67 | ||
| Q3 25 | — | $0.70 | ||
| Q2 25 | — | $0.45 | ||
| Q1 25 | — | $0.27 | ||
| Q4 24 | — | $0.37 | ||
| Q3 24 | — | $0.34 | ||
| Q2 24 | — | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $556.0M | $917.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $10.8B | $2.7B |
| Total Assets | $46.0B | $6.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $917.7M | ||
| Q4 25 | — | $917.7M | ||
| Q3 25 | — | $1.8B | ||
| Q2 25 | $556.0M | $1.2B | ||
| Q1 25 | — | $904.9M | ||
| Q4 24 | — | $606.1M | ||
| Q3 24 | — | $621.2M | ||
| Q2 24 | $614.0M | $939.2M |
| Q1 26 | — | $2.7B | ||
| Q4 25 | — | $2.7B | ||
| Q3 25 | — | $2.7B | ||
| Q2 25 | $10.8B | $2.6B | ||
| Q1 25 | — | $2.3B | ||
| Q4 24 | — | $2.1B | ||
| Q3 24 | — | $2.0B | ||
| Q2 24 | $14.8B | $2.4B |
| Q1 26 | — | $6.3B | ||
| Q4 25 | — | $6.3B | ||
| Q3 25 | — | $7.5B | ||
| Q2 25 | $46.0B | $7.3B | ||
| Q1 25 | — | $6.8B | ||
| Q4 24 | — | $6.5B | ||
| Q3 24 | — | $6.4B | ||
| Q2 24 | $42.6B | $6.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $139.0M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $294.0M | ||
| Q3 25 | — | $659.9M | ||
| Q2 25 | $139.0M | $303.0M | ||
| Q1 25 | — | $183.8M | ||
| Q4 24 | — | $301.4M | ||
| Q3 24 | — | $199.5M | ||
| Q2 24 | $140.0M | $279.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | $192.1M | ||
| Q3 25 | — | $579.4M | ||
| Q2 25 | — | $208.9M | ||
| Q1 25 | — | $96.8M | ||
| Q4 24 | — | $176.8M | ||
| Q3 24 | — | $88.3M | ||
| Q2 24 | — | $213.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | 15.3% | ||
| Q3 25 | — | 47.9% | ||
| Q2 25 | — | 18.1% | ||
| Q1 25 | — | 9.3% | ||
| Q4 24 | — | 15.9% | ||
| Q3 24 | — | 8.9% | ||
| Q2 24 | — | 21.2% |
| Q1 26 | — | — | ||
| Q4 25 | — | 8.1% | ||
| Q3 25 | — | 6.7% | ||
| Q2 25 | — | 8.1% | ||
| Q1 25 | — | 8.4% | ||
| Q4 24 | — | 11.2% | ||
| Q3 24 | — | 11.2% | ||
| Q2 24 | — | 6.6% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.10× | ||
| Q3 25 | — | 2.33× | ||
| Q2 25 | — | 1.69× | ||
| Q1 25 | — | 1.74× | ||
| Q4 24 | — | 1.99× | ||
| Q3 24 | — | 1.48× | ||
| Q2 24 | — | 1.95× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
